AliveCor earns $3M in Series A financing

Mobile electrocardiogram developer AliveCor just snagged a huge cash infusion without even having a product on the market. Wireless and telecom company QualComm, along with the Oklahoma Life Science Fund and a few other investors, handed AliveCor $3 million to help bring its wireless cardiac monitor to market. The device still needs to complete clinical studies, ongoing at the Oklahoma University Health Sciences Center and obtain U.S. Food and Drug Administration approvals before it's ready for commercial launch, company officials say. Announcement